Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-108521
Filing Date
2025-11-07
Accepted
2025-11-07 16:36:12
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 tm2530375d1_s3.htm S-3 257574
2 EXHIBIT 5.1 tm2530375d1_ex5-1.htm EX-5.1 9625
3 EXHIBIT 23.1 tm2530375d1_ex23-1.htm EX-23.1 2536
4 EX-FILING FEES tm2530375d1_ex-filingfees.htm   iXBRL EX-FILING FEES 25506
5 GRAPHIC tm2530375d1_ex5-1img001.jpg GRAPHIC 3136
6 GRAPHIC tm2530375d1_s3img001.jpg GRAPHIC 2892
7 GRAPHIC tm2530375d1_s3img002.jpg GRAPHIC 36533
  Complete submission text file 0001104659-25-108521.txt   477696

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2530375d1_ex-filingfees_htm.xml XML 4882
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-291381 | Film No.: 251463194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)